BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

720 related articles for article (PubMed ID: 26200010)

  • 1. Interferon-λ: Immune Functions at Barrier Surfaces and Beyond.
    Lazear HM; Nice TJ; Diamond MS
    Immunity; 2015 Jul; 43(1):15-28. PubMed ID: 26200010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections.
    Mordstein M; Neugebauer E; Ditt V; Jessen B; Rieger T; Falcone V; Sorgeloos F; Ehl S; Mayer D; Kochs G; Schwemmle M; Günther S; Drosten C; Michiels T; Staeheli P
    J Virol; 2010 Jun; 84(11):5670-7. PubMed ID: 20335250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What have we learned from the IL28 receptor knockout mouse?
    Mordstein M; Michiels T; Staeheli P
    J Interferon Cytokine Res; 2010 Aug; 30(8):579-84. PubMed ID: 20649452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-Stimulated Genes as Enhancers of Antiviral Innate Immune Signaling.
    Crosse KM; Monson EA; Beard MR; Helbig KJ
    J Innate Immun; 2018; 10(2):85-93. PubMed ID: 29186718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-lambda: a new addition to an old family.
    Donnelly RP; Kotenko SV
    J Interferon Cytokine Res; 2010 Aug; 30(8):555-64. PubMed ID: 20712453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.
    Zhang SY; Boisson-Dupuis S; Chapgier A; Yang K; Bustamante J; Puel A; Picard C; Abel L; Jouanguy E; Casanova JL
    Immunol Rev; 2008 Dec; 226():29-40. PubMed ID: 19161414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shared and Distinct Functions of Type I and Type III Interferons.
    Lazear HM; Schoggins JW; Diamond MS
    Immunity; 2019 Apr; 50(4):907-923. PubMed ID: 30995506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type III Interferons in Viral Infection and Antiviral Immunity.
    Zhou JH; Wang YN; Chang QY; Ma P; Hu Y; Cao X
    Cell Physiol Biochem; 2018; 51(1):173-185. PubMed ID: 30439714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-λ orchestrates innate and adaptive mucosal immune responses.
    Ye L; Schnepf D; Staeheli P
    Nat Rev Immunol; 2019 Oct; 19(10):614-625. PubMed ID: 31201377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type III Interferons in Antiviral Defenses at Barrier Surfaces.
    Wells AI; Coyne CB
    Trends Immunol; 2018 Oct; 39(10):848-858. PubMed ID: 30219309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of type III interferon expression.
    Iversen MB; Paludan SR
    J Interferon Cytokine Res; 2010 Aug; 30(8):573-8. PubMed ID: 20645874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type III Interferon-Mediated Signaling Is Critical for Controlling Live Attenuated Yellow Fever Virus Infection
    Douam F; Soto Albrecht YE; Hrebikova G; Sadimin E; Davidson C; Kotenko SV; Ploss A
    mBio; 2017 Aug; 8(4):. PubMed ID: 28811340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional Interplay between Type I and II Interferons Is Essential to Limit Influenza A Virus-Induced Tissue Inflammation.
    Stifter SA; Bhattacharyya N; Pillay R; Flórido M; Triccas JA; Britton WJ; Feng CG
    PLoS Pathog; 2016 Jan; 12(1):e1005378. PubMed ID: 26731100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon lambda in respiratory viral infection: immunomodulatory functions and antiviral effects in epithelium.
    Liu YG; Jin SW; Zhang SS; Xia TJ; Liao YH; Pan RL; Yan MZ; Chang Q
    Front Immunol; 2024; 15():1338096. PubMed ID: 38495892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type III IFNs: Beyond antiviral protection.
    Kotenko SV; Rivera A; Parker D; Durbin JE
    Semin Immunol; 2019 Jun; 43():101303. PubMed ID: 31771761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zika Virus Persistently Infects and Is Basolaterally Released from Primary Human Brain Microvascular Endothelial Cells.
    Mladinich MC; Schwedes J; Mackow ER
    mBio; 2017 Jul; 8(4):. PubMed ID: 28698279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type III interferons (IFNs): Emerging Master Regulators of Immunity.
    Galani IE; Koltsida O; Andreakos E
    Adv Exp Med Biol; 2015; 850():1-15. PubMed ID: 26324342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon Lambda: Toward a Dual Role in Cancer.
    Lasfar A; Zloza A; Silk AW; Lee LY; Cohen-Solal KA
    J Interferon Cytokine Res; 2019 Jan; 39(1):22-29. PubMed ID: 30020822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFN-lambda: novel antiviral cytokines.
    Ank N; West H; Paludan SR
    J Interferon Cytokine Res; 2006 Jun; 26(6):373-9. PubMed ID: 16734557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate and adaptive immune responses in HCV infections.
    Heim MH; Thimme R
    J Hepatol; 2014 Nov; 61(1 Suppl):S14-25. PubMed ID: 25443342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.